SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

11 Nov 2022 Evaluate
A fair growth of 19.41% in the revenue at Rs. 23988.00 millions was reported in the September 2022 quarter as compared to Rs. 20089.00 millions during year-ago period.The Total revenue for the quarter ended September 2022 of  Rs. 4511.00  millions  grew by 3099.29% from Rs. 141.00 millions.Operating profit surged to 7882.00 millions from the corresponding previous quarter of 5537.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 23988.00 20089.00 19.41 43797.00 41323.00 5.99 79819.00 77800.00 2.60
Other Income 1092.00 694.00 57.35 1609.00 991.00 62.36 1787.00 893.00 100.11
PBIDT 7882.00 5537.00 42.35 13842.00 12010.00 15.25 20968.00 23980.00 -12.56
Interest 641.00 241.00 165.98 1047.00 683.00 53.29 1349.00 709.00 90.27
PBDT 7241.00 2103.00 244.32 12795.00 8134.00 57.30 16426.00 21396.00 -23.23
Depreciation 1240.00 1192.00 4.03 2471.00 2359.00 4.75 4787.00 4511.00 6.12
PBT 6001.00 911.00 558.73 10324.00 5775.00 78.77 11639.00 16885.00 -31.07
TAX 1490.00 770.00 93.51 2498.00 1635.00 52.78 3060.00 2123.00 44.14
Deferred Tax 44.00 43.00 2.33 38.00 58.00 -34.48 458.00 -910.00 -150.33
PAT 4511.00 141.00 3099.29 7826.00 4140.00 89.03 8579.00 14762.00 -41.88
Equity 1012.00 1024.00 -1.17 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 32.86 27.56 19.21 31.60 29.06 8.74 26.27 30.82 -14.77

Zydus Lifesciences Share Price

936.50 -6.05 (-0.64%)
20-Apr-2026 14:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.90
Dr. Reddys Lab 1235.10
Cipla 1232.95
Zydus Lifesciences 936.50
Lupin 2327.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×